What is SciSafe?
SciSafe operates as a cGMP-compliant biorepository with over 15 years of specialized experience in biological and pharmaceutical cold storage, clinical trial management, and precision cold chain logistics. The company is a critical service provider for the life sciences industry, offering secure and regulatory-compliant storage solutions for sensitive materials such as clinical trial samples, cell lines, and high-value biologics. Leveraging advanced biostorage technologies and a global infrastructure, SciSafe ensures the integrity of scientific processes through real-time inventory access and robust documentation. Their expertise extends to developing customized solutions tailored to the unique requirements of their clientele, reinforcing their role in advancing scientific research and development.
How much funding has SciSafe raised?
SciSafe has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for SciSafe?
With the recent influx of capital and its established track record in large-scale late-stage funding, SciSafe is strategically positioned for continued expansion and operational enhancement. The company's focus on cGMP compliance and precision cold chain logistics suggests a trajectory towards solidifying its market leadership and potentially broadening its service offerings within the global life sciences ecosystem. Future growth may involve scaling infrastructure, investing in advanced biostorage technologies, and further optimizing its supply chain solutions to meet the evolving demands of clinical trials and biopharmaceutical development. This strategic investment will likely fuel initiatives aimed at enhancing client support and maintaining the integrity of high-value biological assets.
See full SciSafe company page
